Skip to content

A human study to evaluate effects of Platycodi radix water extract on postprandial blood triglycerides: a randomized, double-blind, cross-over, placebo-controlled study

A human study to evaluate effects of Platycodi radix water extract on postprandial blood triglycerides: a randomized, double-blind, cross-over, placebo-controlled study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CRIS
Registry ID
KCT0002296
Enrollment
52
Registered
2017-04-05
Start date
2017-05-29
Completion date
Unknown
Last updated
2019-03-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Dietary Supplement : After 1-week run-in period, subjects are randomly assigned to to one of the six sequence. Each sequence is consist of intervention groups (control group or Platycodi radix water e

Sponsors

Ewha Womans University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1) Subject who voluntarily agree to participate and signs informed consent form 2) 20 years= Age <40 years (Ratio of men and women 1:1) 3) Subject who comply with dietary/exercise guidelines for intervention period

Exclusion criteria

Exclusion criteria: 1) Continuous consumption of health functional food(phytosterol, omega-3 fatty acid, plantagis Semen, aloe, kito acid, onion extract, Indigestible maltodextrin, pure cuttlefish oil, globin hydrolysate), medicine(Lipid-lowering agents, blood glucose-lowering drugs, antihypertensive drugs, anti-inflammatory agents, anticoagulant drug), and oriental medicine that affect blood glucose, lipid, body fat metabolism within 1 months before the first visit 2) History or current abuse of alcohol, or intake = 140 g pure alcohol/week (e.g. more than 2.5 bottles of soju/week) 3) Following diseases ? Liver dysfunction, Diabetes, renal dysfunction, interstinal disease, lactose intolerance, chronic inflammatory disease, thyroid disease, severe muscular skeletal disease ? Severe wasting diseases: malignant tumor ? Mental diseases: schizophrenia, depression ? Cardiovascular and cerebrovascular diseases: hypertension(systolic blood pressure = 160 mmHg, diastolic blood pressure = 100 mmHg), myocardial infarction, stroke ? Anemia, asthma and allergic diseases 4) Women who maintaining hormone therapy 5) Subject who controlling body weight or subjects who have changed of body weight more than 10% within 6 months before the first visit 6) Excessive exercise (= 10 hours / week) 7) Chronic smoker (= 20 cigarettes / day) 8) Recommended Food Score > 36 9) Case of less than 18.5kg/m2 or greater than 30.0kg/m2 in BMI 10) Known hypersensitivity to study product or any ingredient in study product 11) Participation in other human study within 1 month before the first visit 12) Pregnant or lactating women 13) Subject who has difficult to handle smartphone

Design outcomes

Primary

MeasureTime frame
Blood triglyceride

Secondary

MeasureTime frame
Body Mass Index(BMI),Height,Weight

Countries

Korea, Republic of

Contacts

Public ContactHansol Lee

Ewha Womans University

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026